Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Apr 20;49(6):114. doi: 10.3892/or.2023.8551

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Yang et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 1. — TFAP2A expression is increased in cervical cancer and is associated with clinicopathological features. (A-D) Analysis of TFAP2A mRNA expression in different datasets. (E) Expression of TFAP2A mRNA in six sets of paired cancer-paraneoplastic tissue samples. (F) IHC staining of TFAP2A expression and H&E staining in normal and cancer tissues. (G) Analysis of TFAP2A mRNA expression in different FIGO grades. (H) The expression level of the TFAP2A gene in different histopathology grades. (I) The expression level of TFAP2A gene in different FIGO T Stages. (J) The expression level of the TFAP2A gene according to lymph node metastasis. (K) The expression level of TFAP2A gene in association with patient survival. in each group. *P<0.05, **P<0.01 and ***P<0.001. TFAP2A, transcription factor AP-2 alpha; H&E, hematoxylin-eosin; IHC, immunohistochemical.